Dr. Mukesh Prasad ENT

Dr. Kevin Holcomb is the Vice Chair of Gynecology, a member of the Division of Gynecologic Oncology, and Associate Dean of Admission for Weill Cornell Medical College. He is gratified to work with so many gifted colleagues to deliver the benefits of cutting-edge medicine to patients while also overseeing the selection of the next generation of Weill Cornell Medicine trained physicians. He believes strongly in a humanistic approach to medicine, the benefit of personal connections with his patients, and that the quality of patient care is enhanced by mutual respect in the doctor-patient relationship. Dr. Holcomb is committed to providing the most effective treatments for gynecologic cancers while also maximizing the quality of life for his patients. This commitment motivates him to develop and promote innovative robotic and laparoscopic surgical techniques for gynecologic cancer which result in faster recovery and less pain. His multidisciplinary approach to cancer care employs the latest medical therapeutics including immunotherapy and targeted therapies. Dr. Holcomb's research contributions include over 100 peer-reviewed journal articles, book chapters, and abstracts. He has been an invited speaker at multiple regional, national, and international conferences. His research activities include clinical trials of new chemotherapy regimens, outcomes research utilizing large population-based data sets, and innovative collaborations with basic science researchers studying ovarian cancer biology. Dr. Holcomb's dedication to medical education was recognized by the Council on Resident Education in Obstetrics and Gynecology, where he received the National Faculty Award in 2002 and 2004. He has also received recognition for his outstanding clinical care. He has been named one of New York's Top Doctors by New York Magazine, one of the New York Metro Area's Top physicians by Castle-Connolly Medical Ltd., and one of America's Leading Doctors by Black Enterprise magazine. Additionally, Dr. Holcomb served as the President of the Board of Advisors for the American Cancer Society Upper Manhattan Office and was the recipient of the 2011 Chanel Award for Achievement in Obstetrics and Gynecology. "The more I practice, the more I appreciate the training I received here at Weill Cornell Medicine"Dr. Holcomb received his Bachelor of Arts from the Cornell University College Scholar program, a unique experience that allowed him to pursue a well-rounded liberal arts education while completing premedical coursework. He credits this program with providing him the cultural competence and sensitivity to treat the diverse patient population he enjoys in New York City. He earned his medical doctorate from New York Medical College. His post-doctoral training included an internship and residency in Obstetrics and Gynecology at New York Hospital - Cornell Medical Center and a fellowship in Gynecologic Oncology at SUNY Downstate Health Science Center at Brooklyn/Kings County Hospital Center. Before joining the faculty at Weill Cornell Medical College in 2006, Dr. Holcomb served as the Director of Gynecologic Oncology at New York's Beth Israel Medical Center, and Assistant Clinical Professor at the Columbia University College of Physicians and Surgeons.

Dr. Konstantinou is a retina specialist and Assistant Professor of Ophthalmology at Weill Cornell Medical College. Dr. Konstantinou specializes in the medical and surgical treatment of ocular tumors including plaque application, photodynamic therapy, cryotherapy, laser photocoagulopathy of abnormal of retinal diseases, including conditions such as diabetic retinopathy, retinal tears, retinal vein occlusions, and macular diseases, ocular tumors.Dr. Konstantinou graduated in the top 3% from the National and Kapodistrian University of Athens. She received her M.D. from Athens Medical School. Her dream to pursue the rest of her training in the United States brought her to Boston Massachusetts. Throughout a three-year research fellowship at the Massachusetts Institute of Technology (MIT) and Mass Eye and Ear/Harvard, she developed expertise in gene editing techniques, specifically CRISPR-Cas9. She focused on utilizing CRISPR-Cas9 to explore molecular pathways related to Toxoplasma gondii's pathogenicity which resulted in published works in prominent journals and multiple presentations.Dr. Konstantinou completed a surgical internship at the Massachusetts GeneralHospital/Harvard Medical School and then her ophthalmology residency at Tufts. During her residency, she served as Chief resident and also was selected to attend the Heeds resident treat by the department chair. She received the Good Neighbor Award from the University of New Mexico during her last year of residency which is awarded to consultants who demonstrated outside department-wide teaching, role models of patient advocacy, and significant contributors to the success of the clinical environment. During her residency at Tufts/New England Eye Center, she focused on clinical research and imaging of the retina fostering both clinical insight and a passion for innovating the understanding of vision impairment. Her contributions to research, particularly on age-related issues, infectious diseases, and inherited disorders, using new imaging methods for retinal study, led to publications in esteemed journals and invitations to conferences.With her clinical fellowships in medical retina at NIH and ocular oncology at Wills Eye Hospital, she extended her expertise in both clinical care and cutting-edge research of medical retinal and ocular tumors. Some of her research highlights included research to improve medical treatment and clinical outcomes for patients with Von Hippel Lindau syndrome with retinal hemangioblastomas which led to a publication in JAMA Ophthalmology with ongoing work. Going forward, Dr. Konstantinou will continue to focus on diseases of the retina and ocular tumors, on examining and understanding the retina toxicity of medications like pentosan poly sulfate as well as imaging modalities for better screening of ocular tumors, innovative diagnostic tools and treatments for medical retinal diseases and more particular ocular tumors and radiationretinopathy.Dr. Konstantinou is actively engaged in clinical and basic science research in retinal diseases and has published approximately 26 peer-reviewed research articles. She has authored several textbook chapters and has presented her research at national and international meetings. Dr. Konstantinou serves as a scientific reviewer to several major ophthalmology journals.Dr. Konstantinou is currently accepting new patients. She sees general eye patients as well as patients with retinal diseases and ocular oncology.